Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress

The aim of this study was to determine whether a relationship exists between the circulating concentration of antioxidants, or markers of oxidative stress, and pulmonary function in cystic fibrosis patients. Plasma was obtained from 34 patients attending a cystic fibrosis clinic. Oxidative stress was investigated by measuring the concentrations of circulating lipid hydroperoxides and malondialdehyde (lipid peroxidation) and protein carbonyls (protein oxidation). Antioxidant status was determined from the plasma concentrations of alpha-tocopherol, ascorbic acid, uric acid and total sulphydryls. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and forced mid-expiratory flow (FEF25-75) were measured in 25 of the subjects by spirometry, and expressed as percentage predicted for normal height, weight and age. Lung function decreased significantly with age and was associated with decreased plasma alpha-tocopherol, ascorbic acid and sulphydryl concentrations. The reduction in pulmonary function correlated with elevated plasma malondialdehyde, but not with lipid hydroperoxide or protein carbonyl concentrations. Patients with severe lung dysfunction (FEV1 < 50% predicted) had higher plasma concentrations of lipid hydroperoxides than those with mild-to-moderate lung dysfunction (FEV1 > 50% pred). This study provides evidence that cystic fibrosis patients have inadequate antioxidant defences to cope with the elevated oxidative stress that they regularly experience. We believe that recurring oxidative lung injury contributes to the decline in pulmonary function in these patients.

This article has been cited by other articles:

				A. P. Joy and E. A. Cowley 8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152. [Abstract] [Full Text] [PDF]

				L. W. Velsor, C. Kariya, R. Kachadourian, and B. J. Day Mitochondrial Oxidative Stress in the Lungs of Cystic Fibrosis Transmembrane Conductance Regulator Protein Mutant Mice Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 579 - 586. [Abstract] [Full Text] [PDF]

				E. F. McKone, J. Shao, D. D. Frangolias, C. L. Keener, C. A. Shephard, F. M. Farin, M. R. Tonelli, P. D. Pare, A. J. Sandford, M. L. Aitken, et al. Variants in the Glutamate-Cysteine-Ligase Gene Are Associated with Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 415 - 419. [Abstract] [Full Text] [PDF]

				V. Starosta, E. Rietschel, K. Paul, U. Baumann, and M. Griese Oxidative Changes of Bronchoalveolar Proteins in Cystic Fibrosis. Chest, February 1, 2006; 129(2): 431 - 437. [Abstract] [Full Text] [PDF]

				S C Bell, S L Senini, and J G McCormack Macrolides in cystic fibrosis Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98. [Abstract] [PDF]

				B. J. Day Glutathione: A Radical Treatment for Cystic Fibrosis Lung Disease? Chest, January 1, 2005; 127(1): 12 - 14. [Full Text] [PDF]

				A. J. Kettle, T. Chan, I. Osberg, R. Senthilmohan, A. L. P. Chapman, T. J. Mocatta, and J. S. Wagener Myeloperoxidase and Protein Oxidation in the Airways of Young Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1317 - 1323. [Abstract] [Full Text] [PDF]

				E. I Back, C. Frindt, D. Nohr, J. Frank, R. Ziebach, M. Stern, M. Ranke, and H. K Biesalski Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am. J. Clinical Nutrition, August 1, 2004; 80(2): 374 - 384. [Abstract] [Full Text] [PDF]

				P. H. C. Klijn, J. van der Net, J. L. Kimpen, P. J. M. Helders, and C. K. van der Ent Longitudinal Determinants of Peak Aerobic Performance in Children With Cystic Fibrosis Chest, December 1, 2003; 124(6): 2215 - 2219. [Abstract] [Full Text] [PDF]

				F.J. Kelly, C. Dunster, and I. Mudway Air pollution and the elderly: oxidant/antioxidant issues worth consideration Eur. Respir. J., May 1, 2003; 21(40_suppl): 70S - 75s. [Abstract] [Full Text] [PDF]

				L. G Wood, D. A Fitzgerald, A. K Lee, and M. L Garg Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function Am. J. Clinical Nutrition, January 1, 2003; 77(1): 150 - 159. [Abstract] [Full Text] [PDF]

				P. Paredi, S. A. Kharitonov, and P. J. Barnes Analysis of Expired Air for Oxidation Products Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S31 - 37. [Abstract] [Full Text] [PDF]

				L. G Wood, D. A Fitzgerald, P. G Gibson, D. M Cooper, and M. L Garg Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients Am. J. Clinical Nutrition, April 1, 2002; 75(4): 668 - 675. [Abstract] [Full Text] [PDF]

				L. Gao, J. R. Broughman, T. Iwamoto, J. M. Tomich, C. J. Venglarik, and H. J. Forman Synthetic chloride channel restores glutathione secretion in cystic fibrosis airway epithelia Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L24 - L30. [Abstract] [Full Text] [PDF]

				G. CIABATTONI, G. DAVI, M. COLLURA, L. IAPICHINO, F. PARDO, A. GANCI, R. ROMAGNOLI, J. MACLOUF, and C. PATRONO In Vivo Lipid Peroxidation and Platelet Activation in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1195 - 1201. [Abstract] [Full Text] [PDF]

				A. Van der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross Myeloperoxidase and protein oxidation in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L537 - L546. [Abstract] [Full Text] [PDF]

				P. PAREDI, S. A. KHARITONOV, D. LEAK, P. L. SHAH, D. CRAMER, M. E. HODSON, and P. J. BARNES Exhaled Ethane Is Elevated in Cystic Fibrosis and Correlates with Carbon Monoxide Levels and Airway Obstruction Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1247 - 1251. [Abstract] [Full Text]

				P. Montuschi, S. A Kharitonov, G. Ciabattoni, M. Corradi, L. van Rensen, D. M Geddes, M. E Hodson, and P. J Barnes Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis Thorax, March 1, 2000; 55(3): 205 - 209. [Abstract] [Full Text]

				J. D Antuni, S. A Kharitonov, D. Hughes, M. E Hodson, and P. J Barnes Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis Thorax, February 1, 2000; 55(2): 138 - 142. [Abstract] [Full Text]

				K. Takeyama, K. Dabbagh, J. Jeong Shim, T. Dao-Pick, I. F. Ueki, and J. A. Nadel Oxidative Stress Causes Mucin Synthesis Via Transactivation of Epidermal Growth Factor Receptor: Role of Neutrophils J. Immunol., February 1, 2000; 164(3): 1546 - 1552. [Abstract] [Full Text] [PDF]

				L T McGrath, P Mallon, L Dowey, B Silke, E McClean, M McDonnell, A Devine, S Copeland, and S Elborn Oxidative stress during acute respiratory exacerbations in cystic fibrosis Thorax, June 1, 1999; 54(6): 518 - 523. [Abstract] [Full Text]

				J. Hull and A. H Thomson Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis Thorax, December 1, 1998; 53(12): 1018 - 1021. [Abstract] [Full Text]